Community pharmacists‘ attitudes towards clinical utility and ethical implications of pharmacogenetic testing

By Tuteja Sony   Haynes Kevin   Zayac Cara   Sprague Jon E   Bernhardt Barbara   Pyeritz Reed  

Personalized Medicine, Vol. 10, Iss. 8, 2013-11 ,pp. : 793-800

Future Medicine

Access to resources Recommend Favorite

Clinical implications of pharmacogenetic and microarray testing for advanced practice nurses

By  

JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (ELECTRONIC), Vol. 27, Iss. 5, 2015-05 ,pp. : 246-255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Meaningful Use and Clinical Utility of Preemptive Pharmacogenetic Testing: (Re)View From a CYP2D6 Poor Metabolizer

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 119-121

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA's draft guidance on laboratory‐developed tests increases clinical and economic risk to adoption of pharmacogenetic testing

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 725-727

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA oversight of laboratory‐developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 728-730

John Wiley & Sons Inc

Access to resources Recommend Favorite